Skip to main content
ZBIO
NASDAQ Life Sciences

FDA Accepts Obexelimab BLA with May 2027 PDUFA Date; Zenas Reports $673.9M Cash

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$31.3
Mkt Cap
$1.975B
52W Low
$13.5
52W High
$44.6
52W Position info
132% above low
Off High info
30% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

ZBIO has more than doubled off its 52-week low of $13.5.

Summary

Zenas BioPharma reported Q2 2026 results with $673.9 million in cash and investments, extending runway well beyond the May 2027 PDUFA date. The FDA accepted the obexelimab BLA for IgG4-RD with a target action date of May 27, 2027, a major regulatory milestone. Phase 3 INDIGO data showed a 56% reduction in flare risk and was published in NEJM, strengthening the commercial case. Additional catalysts include Phase 2 SLE topline data in Q4 2026 and initial Phase 1 data for ZB021 by year-end. The CFO transition and board expansion add execution depth ahead of potential commercialization.

At the time of this announcement, ZBIO was trading at $31.30 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2B. The 52-week trading range was $13.50 to $44.60. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

ZBIO - Latest Insights

ZBIO
Nov 05, 2026, 7:19 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $28.46
Real-time Price: $27.69 info
Change: -$0.770 (-3%) info
Market Cap: $1.878B info
ZBIO
Nov 05, 2026, 7:00 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $28.46
Real-time Price: $27.69 info
Change: -$0.770 (-3%) info
Market Cap: $1.878B info
ZBIO
Oct 13, 2026, 6:01 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $26.40
Real-time Price: $27.69 info
Change: +$1.29 (+5%) info
Market Cap: $1.878B info
ZBIO
Aug 19, 2026, 4:15 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $31.04
Real-time Price: $27.69 info
Change: -$3.35 (-11%) info
Market Cap: $1.878B info
ZBIO
Aug 13, 2026, 7:15 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $31.30
Real-time Price: $27.69 info
Change: -$3.61 (-12%) info
Market Cap: $1.878B info